Your browser doesn't support javascript.
loading
Hypoxia-induced antizyme inhibitors 2 regulates cisplatin resistance through epithelia-mesenchymal transition pathway in non-small cell lung cancer.
Shi, Qin; Chen, Qiaolin; Zhou, Zhan; Zheng, Xiuxia; Huang, Xinhui; Fang, Minshan; Hu, Ying; Song, Li; Yang, Hualing; Chen, Qun.
Afiliação
  • Shi Q; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China. Electronic address: shiqin2020@126.com.
  • Chen Q; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Zhou Z; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Zheng X; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Huang X; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Fang M; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Hu Y; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Song L; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Yang H; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China.
  • Chen Q; Department of Oncology, Fujian Fuzhou Pulmonary Hospital, No. 2 Shangdu Hubian, Cangshan District, Fuzhou, 350000, Fujian, China. Electronic address: 1326368774@qq.com.
Pulm Pharmacol Ther ; 69: 102048, 2021 08.
Article em En | MEDLINE | ID: mdl-34082109

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article